Lightning-Fast Discoveries Powered By High-Content Screening

High-content screening (analysis) was invented by and registered as a trademark of Cellomics, which is now part of Thermo Fisher Scientific. Since the introduction of Thermo Scientific™ ArrayScan™ high-content screening (HCS) readers in 1998, over 2,000 peer-reviewed Cellomics publications attest to a legacy of innovation and scientific excellence of the Thermo Scientific™ CellInsight™ CX5, CX7 LED, and CX7 LZR HCS platforms and Thermo Scientific™ HCS Studio™ software.

Our HCS instruments combine fluorescence imaging, image processing, automated cellular measurements using our cutting-edge algorithms, and informatics tools to extract quantitative data from cell populations. This powerful technology has enabled fundamental discoveries in basic research and advancements in drug-compound discovery.